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ABSTRACT
The vascular endothelial growth factor receptor, Flt1
is a transmembrane receptor co-expressed with an
alternate transcript encoding a secreted form, sFlt1,
that functions as a competitive inhibitor of Flt1.
Despite shared transcription start sites and
upstream regulatory elements, sFlt1 is in far greater
excess of Flt1 in the human placenta. Phorbol
myristic acid and dimethyloxalylglycine differentially
stimulate sFlt1 compared to Flt1 expression in
vascular endothelial cells and in cytotrophoblasts.
An FLT1 minigene construct containing exon 13, 14
and the intervening region, recapitulates mRNA pro-
cessing when transfected into COS-7, with chimeric
intronic sFlt1 transcripts arising by intronic
polyadenylation and other Flt1/sFlt1 transcripts by
alternate splicing. Inclusion of exon 15 but not 14
had a modest stimulatory effect on the abundance
of sFlt1. The intronic region containing the distal
poly(A) signal sequences, when transferred to a
heterologous minigene construct, inhibited splicing
butonlywhenclonedinsenseorientation,consistent
with the presence of a directional cis-element. Serial
deletional and targeted mutational analysis of cis-
elements within intron 13 identified intronic poly(A)
signal sequences and adjacent cis-elements as
the principal determinants of the relative ratio of
intronic sFlt1 and spliced Flt1. We conclude that
intronic signals reciprocally regulate splicing and
polyadenylation and control sFlt1 expression.
INTRODUCTION
Fms-like tyrosine kinase-1 (Flt1) is one of three principal
receptors for vascular endothelial growth factor (VEGFR)
regulating angiogenesis and vasculogenesis (1–3). A
soluble form of the receptor (sFlt1) binds VEGF with an
aﬃnity equal to Flt1 and thus is a natural VEGF antag-
onist and potent anti-angiogenic factor whose physiolog-
ical and pathological roles are just beginning to be
understood. For example, the normal corneal avascularity
from dugong to human appears to be due to selective sFlt1
expression in the cornea (4). Conditional disruption of
sFlt1 in mice leads to vascularized corneas and adminis-
tration of sFlt1 re-establishes corneal avascularity in
Pax6+/-mice who have sFlt1 deﬁciency and vascularized
corneas. Spatially regulated secretion of sFlt1 in areas
adjacent to an emerging blood vessel sprout leaves a
VEGF-rich path that directs sprouts away from the
parent vessel and permits the creation of an elegant
vascular network early in angiogenesis (5). Placental over-
production of sFlt1 may contribute to the syndrome of
preeclampsia with proteinuria and hypertension since re-
combinant sFlt1 induces proteinuria in pregnant and
non-pregnant rodents (6–8).
Flt1 and sFlt1 mRNAs arise from the gene, FLT1 and
the mRNAs have a common transcription start site. Flt1
contains 30 spliced exons and sFlt1 shares the ﬁrst 13 or
14 exons and utilizes alternative poly(A) signal sequences
to create alternate transcripts with a shorter open reading
frame (9–13). Full-length Flt1 is 180–200kDa in size and
contains an extracellular ligand binding domain, a
membrane spanning segment, and a C-terminal intracellu-
lar tail that contains the tyrosine kinase domains. The al-
ternate transcripts of sFlt1 encode glycosylated protein
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membrane-spanning and tyrosine kinase domains and
are secreted proteins (12–14).
In some tissues, such as in the normal cornea and
placenta, and in a pathophysiological state like
preeclampsia, the increase in sFlt1 is not always
matched by a corresponding increase in Flt1 expression
(4,15–17). Since Flt1 and sFlt1 share the same transcrip-
tion start site with common upstream regulatory cis-
elements, the selective overexpression of sFlt1 mRNA is
likely mediated by post-transcriptional regulation. sFlt1
arises by one of two principal mechanisms: intronic
polyadenylation or alternate splicing. In the ﬁrst, the
sFlt1 transcript arises when splicing of exon 13 to exon
14 does not occur and instead the transcript reads through
into intron 13 and utilizes one of three polyadenylation
signal sequences to form transcripts, sFlt1-i13s and
sFlt1-i13l, that do not include exons 14–30 (11). In the
second, the sFlt1 transcript splices normally from exons
13–14 and then splices to one of two alternate exons, exon
15a or 15b, where it terminates to create sFlt1_v2
(sFlt1-e15a) or sFlt1_v3 or reads through into intron 14
to create sFlt1_v4 (13,14). Little is known about factors
that regulate upstream polyadenylation to yield sFlt1-i13,
or those that regulate splicing of exon 13 to exon 14 and
beyond to yield Flt1. In alternatively spliced and/or
polyadenylated transcripts, competition between splicing
signals and polyadenylation signals may determine the net
balance between splicing and cleavage/polyadenylation at
a given site (18). An increase in the expression of sFlt1-i13
could thus result from robust cis-elements and trans-acting
factors that favor polyadenylation within intron 13 or
from relatively weak elements that regulate splicing
further downstream. We hypothesized that cis-elements
within intron 13 may preferentially direct processing of
the transcribed FLT1 gene to sFlt1. In this article, we
identify regulatory sequences within intron 13 that recip-
rocally regulate intronic polyadenylation and splicing.
MATERIALS AND METHODS
Cell culture
Primary cultures of human umbilical vein endothelial cells
(HUVEC), uterine microvascular endothelial cells
(UtMVEC) (Cambrex Corporation, East Rutherford,
NJ, USA) and human microvascular endothelial cells
(HMEC-1) were cultured in Endothelial Growth
Medium-2 (Cambrex Corporation) with 2% fetal bovine
serum (FBS). Primary cytotrophoblasts (CTB) were
isolated from term placenta as previously described
(11,19). These CTBs were cultured in 6-well plates in
Ham’s F10/Waymouth (1:1 vol/vol) media (HWM) con-
taining 10% FBS. COS-7 cells were cultured in Dulbecco’s
modiﬁed Eagle medium (DMEM) and JEG-3 cells in
minimum essential medium (MEM), both containing
10% FBS. The HTR-8/SVNeo cell line was a gift from
Charles Graham and was grown in DMEM/F12 (1:1) with
10% serum. In some cases, vascular endothelial cells were
treated with 30 nM phorbol myristic acid (PMA) (Enzo
Life Sciences, Plymouth Meeting, PA, USA) for 4h and
JEG-3 cells were treated with dimethyloxalyl glycine
(DMOG) (Frontier Scientiﬁc, Logan, UT, USA) for
48h. In other instances, CTBs and JEG-3 cells were
placed in humidiﬁed hypoxia chambers (Billups-
Rothenburg, Del Mar, CA, USA) and subjected to a
2% or 8% O2 mixture at 37 C for 48h.
Minigene plasmid construction
To measure splicing and intronic polyadenylation, a
6010nt genomic fragment of the Flt1 gene that includes
exon 13, intron 13 and exon 14, as well as  500bp of
intronic sequence ﬂanking exon 13 and 14 was ampliﬁed
from human placental DNA using primers hFlt1intronF1
and hFlt1intronR1 (Table 1). This minigene cassette was
then cloned into the multiple cloning site of the splicing
vector pL53In between exons 2 and 3 of the rat insulin
gene to create pL53In_Flt1/13+14. To map processing
elements, various deletions of pL53In_Flt1/13+14 were
created by restriction enzyme digestion within intron 13.
The putative proximal intronic sFlt1 polyA signal
sequence ATTAAA was mutated to ATTAGAb y
Quikchange
TM site-directed mutagenesis (Stratagene, La
Jolla, CA, USA) with primers prox_polyA_mutF and
prox_polyA_mutR (Table 1). The distal intronic sFlt1
polyA signal sequences A2 and A4 were mutated as pre-
viously described (11). To test intronic Flt1 sequence with
heterologous exons, a 1221nt SpeI–NheI fragment of
intron 13 was cloned into the multiple cloning site of
pL53In. Other minigene constructs were created by
introducing, in various combinations, individual exons
from 13 to 15 with adjacent splicing signals into pL53In.
The plasmids were introduced into COS-7 cells by electro-
poration at 950mF and 3200V with a Gene Pulser II
(Bio-Rad; Hercules, CA, USA) and into JEG-3 cells by
transfection with Lipofectamine 2000. The cells were then
plated in standard culture media and RNA was isolated
48h later.
PolyA reporter assay
A 286bp PstI–SmaI fragment that included the putative
proximal polyA signal sequences at the 50-end of intron 13
was isolated by restriction digestion from the previously
Table 1. Primers used for PCR ampliﬁcation
hFlt1intronF1 CTCGAGTCACCCCCACCAAAAAGTACA
hFlt1intronR1 GAGCTCGCCGTCATGGTGAACTGAATC
prox_polyA_mutF CAAAGTAATGTAAAACATTAGTCGACTCATTAAAAAGTAACAG
prox_polyA_mutR CTGTTACTTTTTAATGAGTCGACTAATGTTTTACATTACTTTG
ins_exon2_F CGATCCGCTTCCTGCCCC
ins_exon3_R CGGGCCACCTCCAGTGCC
sFlt1_R TCTCCTCCGAGCCTGAAAGTT
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the multiple cloning site of the polyadenylation signal
reporter vector, pCbS, to create pCbS/sFlt1prox. The
putative proximal intronic sFlt1 polyA signal sequence
ATTAAA was mutated to ATTAGA by Quikchange
TM
site-directed mutagenesis with primers prox_polyA_mutF
and prox_polyA_mutR. The bovine growth hormone
polyA signal sequence in pCbS clones were removed by
XhoI digestion and then the plasmids were introduced
into HTR-8/SVNeo by electroporation at 600 mF and
200V with a Gene Pulser II (Bio-Rad) and plated in
standard culture media and RNA was isolated as previ-
ously described (11).
RNA preparation and ribonuclease protection assays
Total RNA from cell cultures was prepared with the
Absolutely RNA miniprep kit (Stratagene, La Jolla,
CA, USA) or with the RNeasy Mini Kit (Qiagen,
Valencia, CA, USA). To simultaneously measure sFlt1
and Flt1 mRNA levels by ribonuclease protection assays
(RPA), a 364bp Flt1 cDNA, containing contiguous
portions of exon 13 and exon 14, was used as a template
for synthesis of an antisense cRNA probe as previously
described (11). This cRNA probe detects a 364nt product
that includes all transcripts that splice exon 13 to exon 14
and a 269nt sFlt1 product that includes all transcripts that
read through into intron 13 and was also used to identify
processed transcripts from minigene constructs containing
exons 13 and 14 of FLT1. To map mRNA cleavage
from the polyadenylation signal reporter vector,
pCbs-sFlt1prox, the construct was linearized and used to
synthesize cRNA probes as described (11). To measure
splicing of exon 2 to exon 3 of the rat insulin gene, an
842nt product containing exon 2, exon 3 and intervening
sequence was ampliﬁed from the splicing vector pL53In
using primers ins_exon2_F and ins_exon3_R (Table 1)
and cloned into pCRXL-topo and then a 575bp AvrII–
XbaI–XbaI fragment was trimmed from the inserted
sequence to create pCRXL_ins_exon2. This was linearized
and used for synthesis of an antisense cRNA probe. This
cRNA probe will protect a 176nt exon 2 product if
splicing occurs and a 272nt product if the transcript is
unspliced and reads into the intervening sequence. In all
cases RPA was performed as previously described (20).
RT–PCR and qRT–PCR
Flt1 and sFlt1 mRNA were ampliﬁed from CTB by
real-time PCR as previously described (14). RNAs from
transfected COS-7 and JEG-3 cells were subject to reverse
transcription with AﬃnityScript QPCR cDNA synthesis
kit (Stratagene) under the following conditions: 5min in-
cubation at 25 C for primer annealing, 42 C for 45min
for cDNA synthesis and 5min termination at 95 C.
Chimeric transcripts that included insulin exon 2 and
insulin exon 3 sequences were ampliﬁed with forward
(ins_exon2_F) and reverse primers (ins_exon3_R) corres-
ponding to sequence in exon 2 and exon 3 of pL53In
(Table 1). Transcripts from minigene constructs that
terminated within intron 13 were identiﬁed with the
same forward primer and the reverse primer, sFlt1_R
(Table 1). Real-time PCR reactions for these processed
minigenes were performed with Brilliant SYBR Green
QPCR master mix (Stratagene) with the following cycling
conditions: 1 cycle for 10min at 95 C followed by 30–45
cycles (15–25 cycles for 18S rRNA) of 30s denaturation at
95 C, 1min annealing at 55–60 C and 1min extension at
72 C. The number of cycles, annealing temperature and
extension time were varied as appropriate for the abun-
dance of transcripts, the Tm of primers and the size of
amplicons as previously described (11). All reactions
were performed in a Mx3000p Multiplex Quantitative
PCR system (Stratagene) and dissociation curves were
generated for all samples.
RESULTS
Flt1 and sFlt1 are membrane-bound and circulating forms
of a VEGF receptor necessary for normal angiogenesis
that are expressed in both vascular endothelial cells and
in cytotrophoblasts. sFlt1 binds VEGF and placental
growth factor (PlGF) with an aﬃnity equal to Flt1; con-
sequently, this soluble receptor can inhibit VEGF both
locally where it is produced and in distant vascular beds
(6,7). Since sFlt1 has autocrine, paracrine and endocrine
eﬀects, calibrating the local and systemic actions of
VEGF/PlGF necessitates exquisite control of sFlt1 expres-
sion. There are several alternate transcripts for sFlt1
and three of these are generated by utilization of
polyadenylation signal sequences within intron 13 to
create a composite 30-terminal exon (11,14). To begin to
study the regulation of Flt1 and sFlt1 expression we
examined the eﬀect of protein kinase C (PKC) activation
in HUVEC. We used a riboprobe that identiﬁes all forms
of sFlt1 that terminate within intron 13 and diﬀerentiates
them from all other transcripts that splice from exon 13 to
exon 14 including Flt1 (for schematic of sFlt1 transcripts,
see Supplementary Figure S1). PKC activation increased
spliced Flt1 and intronic sFlt1 expression, with the
increase in intronic sFlt1 expression signiﬁcantly greater
than the spliced Flt1 (Figure 1A and B). We saw a similar
increase with PKC activation in HMEC-1 and UtMVEC,
two other vascular endothelial cells. As all sFlt1 and Flt1
mRNAs are expressed from the gene FLT1 and share the
same transcription start site with common upstream regu-
latory elements, this diﬀerential increase suggested that
intronic sFlt1 expression is post-transcriptionally
regulated by PKC. PMA did not stimulate luciferase ex-
pression in transfected HUVEC cells expressing the
reporter gene under the control of the proximal Flt1
promoter (data not shown), also consistent with
a post-transcriptional eﬀect. We tested the eﬀect of
hypoxia in cultured primary CTB and demonstrated that
although both spliced Flt1 and intronic sFlt1 were
increased; the rise in sFlt1 was disproportionately
greater than Flt1 (Figure 1C and D). We saw a similar
eﬀect on intronic sFlt1 with hypoxia and with DMOG, a
hypoxia-mimic, in JEG-3 cells, again consistent
with post-transcriptional regulation of the intronic
form of sFlt1.
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sFlt1_v3 and sFlt1_v4, that terminate after exon 14 were
expressed in very low abundance in CTB and HUVEC
compared to both sFlt1 and Flt1 (Supplementary Figure
S2). We then focused our eﬀorts on the regulation of the
intron 13 form of sFlt1. Given the diﬀerential increase in
the intron 13 form of sFlt1, we reasoned that cis-elements
within intron 13 may regulate the synthesis of intronic
sFlt1 mRNA by intronic polyadenylation or the synthesis
of Flt1 by splicing of exon 13 to exon 14 or both in a
reciprocal manner. We have previously conﬁrmed the
presence of two polyA signal sequences that are 124bp
apart, towards the 30-end of intron 13, which generate
 7 Kb sFlt1 transcripts (sFlt1-i13l) with an unusually
long 30-UTR (11). The other intronic sFlt1 transcript
(sFl1-i13s) appears to have a 30-UTR of just 30nt; a
putative signal sequence found just upstream of the
polyadenylation site of sFlt1-i13s is presumed to direct
the cleavage and polyadenylation of this transcript (11).
To begin to examine the mechanisms that regulate
splicing and intronic polyadenylation of FLT1, we con-
structed an sFlt1/Flt1 minigene in an exon-trap vector
containing authentic 50 and 30 exons such that it will
permit transcription initiation, splicing and
polyadenylation when transfected into cells in culture.
The plasmid, pL53In has the exon trap cassette driven
by an RSV promoter with the leader sequences coming
from the placental alkaline phosphatase gene and exon 2
of the rat preproinsulin II gene. The 30-end of this tran-
scriptional unit has exon 3 of the rat preproinsulin II gene
that includes a poly(A) signal sequence (Figure 2A).
A genomic fragment of the FLT1 gene that includes
exon 13, intron 13 and exon 14 in its entirety was cloned
into pL53In to create pL53In_Flt1/13+14. We reasoned
that all of the relevant cis-elements required for the
readthrough from exon 13 into intron 13 (to create
intronic sFlt1) and for splicing of exon 13 to exon 14
(to create Flt1) would be contained within this gene
fragment. In the assembled construct, the cleavage and
polyadenylation of chimeric ‘Flt1’ would be directed by
poly(A) signal sequences downstream (in exon 3 of the
insulin gene), while the cleavage and polyadenylation of
chimeric intronic sFlt1 would be directed by poly(A)
signals within intron 13 of FLT1. To validate this con-
struct as a model to study the regulation of exon 13 to
exon 14 splicing and the regulation of intronic
polyadenylation, we transfected the expression vector,
pL53In/Flt1 into COS-7 cells and then identiﬁed the
transcribed and processed transcripts by RT–PCR. The
spliced chimeric ‘Flt1’ transcript was ampliﬁed with a
50-primer within exon 2 of insulin and a 30-primer within
exon 3 of insulin and the spliced chimeric sFlt1 transcript
was identiﬁed with the same forward primer and a reverse
primer within intron 13 corresponding to transcribed
sequence of sFlt1. We were able to amplify products of
the predicted 695bp and 661bp which were then
sequenced to conﬁrm that these products corresponded
to the appropriately processed chimeric Flt1 and sFlt1,
respectively (Figure 2B). We then transfected the
minigene construct into COS-7 cells and measured the
relative abundance of both processed transcripts simultan-
eously with an RPA probe that diﬀerentiates intronic
‘sFlt1’ from spliced ‘Flt1’. We ﬁnd that virtually all of
the processed RNA corresponded to intronic sFlt1 with
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Figure 1. Diﬀerential regulation of sFlt1 and Flt1 transcripts in vascular endothelial cells and trophoblasts determined by RPA and qRT–PCR. An
Flt1 cDNA used as template to construct a cRNA probe detects both intronic sFlt1 and spliced Flt1 simultaneously. An 18S rRNA probe is used as
a loading control for RPA. (A) RPA demonstrating that PMA treatment diﬀerentially increases intronic sFlt1 mRNA in HMEC-1, UtMVEC and
HUVEC. (B) Aggregate data from several experiments demonstrating that PMA stimulates sFlt1 expression to a greater extent than Flt1 in HUVEC.
n=4±SEM, *P<0.01 compared to Flt1. (C) RPA demonstrates that DMOG or hypoxia (2% O2) stimulates intronic sFlt1 expression to a greater
extent than Flt1 in JEG-3 cells and CTB. (D) qRT–PCR conﬁrms that hypoxia (2% O2) stimulates sFlt1 expression to a greater extent than Flt1 in
CTB. n=3±SEM, *P<0.001 compared to corresponding 8% O2 value.
Nucleic Acids Research, 2010,Vol.38, No. 15 5133little splicing of exon 13 to exon 14 (Figure 2C). The data
indicate that this minigene construct can be used to
identify cis-elements that regulate readthrough into
intron 13 and those that regulate splicing of exon 13 to
exon 14.
We then created a series of deletion constructs to
identify cis-elements within intron 13 that regulate pro-
cessing of Flt1. In contrast to the full-length construct,
deletion of a  4300bp SmaI–NheI intronic fragment
switched processing almost completely to spliced
‘Flt1’, clearly demonstrating that cis-elements within
intron 13 regulate both polyadenylation and splicing
(Figure 3A–C). The shift from intronic polyadenylation
to splicing was not from loss of all polyadenylation
signal sequences since the proximal sFlt1 polyA signal
sequence is still present in the largest deletion construct.
We demonstrate that as the deleted region gets progres-
sively smaller in a 50–30 direction, there is progressively less
splicing to Flt1 (Figure 3B and C). This suggests that there
are cooperative or additive interactions between upstream
cis-elements and the distal polyA sites that promote pro-
cessing to intronic sFlt1 and that the loss of the distal
polyA sites was still suﬃcient to stimulate modest
splicing of exon 13 to exon 14.
To determine if the upstream elements could function to
switch splicing independently of the distal polyA sites
between AﬂlIII and NheI, we created another series of
deletions which did not include the AﬂIII–NheI region.
We demonstrate that the eﬀect of deletions between
SmaI and AﬂIII are small and insigniﬁcant compared to
the eﬀect of the removal of a AﬂIII–NheI fragment at the
30-end of intron 13 conﬁrming that the primary determi-
nant of intronic processing to sFlt1 in this series of
constructs is the cis-element containing the distal polyA
sites (Figure 4A–C).
To conﬁrm that the regulatory elements at the 30-end of
intron 13, which included the distal polyadenylation signal
sequences, were suﬃcient to inhibit splicing and promote
intronic polyadenylation, we transferred a  1200nt distal
fragment in sense and antisense orientation into pL53In
between insulin exons 2 and exon 3. In the parent
minigene plasmid, the principal processed RNA arises
from splicing of exon 2 to exon 3. The splicing of exon 2
to exon 3 is signiﬁcantly shifted to intronic
polyadenylation giving rise to an unspliced transcript
but only when the intron 13 fragment is cloned in sense
orientation (Figure 5A–C). This is consistent with the
known presence, within this construct, of the distal
polyA signal sequences, which is expected to be a direc-
tional cis-element. When the intron 13pA site is
introduced, the unspliced transcript does not increase as
much as the spliced transcript is decreased probably re-
ﬂecting the relative instability of the unspliced transcript
compared to the spliced transcript, although this was not
formally tested.
The results thus far suggested that the region containing
the distal polyA signal sequences had a profound eﬀect on
polyadenylation of sFlt1. We had also identiﬁed, by
sequence analysis, a putative proximal polyA signal
sequence just upstream of the polyadenylation site of the
2.6 Kb sFlt1 transcript (11). To study the regulation of
this short transcript, we ﬁrst performed a polyadenylation
assay to conﬁrm the identity of the proximal poly(A)
signal sequence. We cloned a genomic DNA fragment
from FLT1 that included the putative proximal mRNA
cleavage site into pCbS and introduced this construct into
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Figure 2. An Flt1/sFlt1 minigene construct is processed primarily to sFlt1. (A) Schematic of pL53In vector with the minigene cassette containing
exon 13, 14 and ﬂanking intronic sequence of FLT1 (6010bp) cloned between to create pL53In_Flt1/13+14 and is shown above. Primers used for
PCR in (B) are shown as solid arrowheads. Relevant chimeric products transcribed from this minigene are also shown. (B)R T –PCR analysis from
transfected COS-7 cells conﬁrms that the insulin/Flt1 hybrid gene is appropriately processed to yield two chimeric transcripts. Asterisk is a minor
transcript where exon 13 is spliced out. (C) RPA demonstrating relative abundance of transfected processed intronic sFlt1 and processed spliced
‘Flt1’. Digested RNA samples are run alongside yeast RNA (negative control) and (undigested) probe. No signal for human sFlt1 or Flt1 is detected
in cells transfected with empty plasmid. When the pL53In_Flt1/13+14 construct (full length) is transfected, the predominant processed product
corresponds to intronic sFlt1 with very little Flt1 formed.
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Cleavage of the resulting chimeric transcript is directed
by a polyA signal sequence within the cloned FLT1
fragment and was identiﬁed by an RPA using an antisense
cRNA probe derived from the sFlt1 construct. RNA from
cells transfected with the proximal sFlt1 construct
sequence showed a strong signal at  170nt, which is
 20nt downstream of the putative proximal sFlt1
poly(A) signal sequence, where we would predict RNA
cleavage and polyadenylation would occur (Figure 6B).
When the putative signal sequence ATTAAA was
mutated, cleavage of the chimeric transcript was abolished
conﬁrming the identity of the proximal intronic sFlt1
polyA signal sequence (Figure 6C). This signal sequence
is quite interesting and unusual as it contains the stop
codon for intronic sFlt1, thus deﬁning both the COO
terminus of intronic sFlt1 and the 30-end of this transcript.
Having conﬁrmed the proximal and distal polyA signal
sequences, we then deleted the region containing the
proximal polyA signal sequence alone (pA signal and
downstream 131nt) and in combination with the distal
region (pA signals and adjacent 762nt) to determine the
eﬀect on splicing of exon 13 to exon 14. We show that
deletion of the proximal polyA signal sequence with
adjacent elements had a small but signiﬁcant eﬀect to
increase splicing of exon 13 to exon 14 (Figure 7A–C).
When both proximal and distal signals and the adjacent
regions are removed there is now a near complete shift in
mRNA processing to splicing of exon 13 to exon 14. These
data indicate that, at least under the conditions tested, the
primary transcripts of FLT1 are preferentially processed
to intronic sFlt1 because of positive regulatory elements
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marily to intronic sFlt1, and the largest deletions leads primarily to
spliced Flt1. Progressive 50–30 deletions lead to a fall in processed
Flt1. (C) Pooled quantitated data from several experiments with the
Flt1 to sFlt1 ratio in each condition expressed as fold increase
compared to the ratio in the full-length construct. n=3,
mean±SEM, *P<0.01, ANOVA (by ranks).
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Figure 4. The AﬂIII–NheI region of FLT1 intron 13 is required to
signiﬁcantly reduce splicing of exon 13 to exon 14. (A) Schematic rep-
resentation of human FLT1 gene in the region of exons 13 and 14. The
position of the putative proximal poly(A) signal sequence, the known
distal poly(A) signal sequences and the restriction sites used to map cis-
elements is shown. (B) RPA demonstrating relative abundance of
intronic sFlt1 and spliced Flt1 in COS-7 cells transfected with a
series of Flt1 minigene constructs. The full-length construct leads pri-
marily to intronic sFlt1, and deletions that do not remove the distal
polyA sites do not substantially increase the abundance of spliced Flt1.
Deletion of the region between AﬂIII and NheI, has a signiﬁcant eﬀect
on processing to spliced Flt1. (C) Pooled quantitated data from several
experiments with the Flt1 to sFlt1 ratio in each condition expressed as
fold increase compared to the ratio in the full-length construct. n=4,
mean±SEM, P<0.001, ANOVA, *P<0.05 compared to each of the
other samples.
Nucleic Acids Research, 2010,Vol.38, No. 15 5135within intron 13 that are clustered around the poly(A)
signal sequences.
To speciﬁcally evaluate the role of sFltl polyA signal
sequences in regulating exon 13 to exon 14 splicing, we
introduced nucleotide substitutions into the proximal and
distal poly(A) signal sequences while leaving adjacent
elements intact within the full-length pL53In/Flt1 con-
struct. Our data shows that selective mutation of the
proximal polyA signal sequence increases exon 13 to
exon 14 splicing and that mutation of both proximal
and distal polyA signal sequences together further in-
creases splicing (Figure 7D–F). These data indicate that
the presence of intronic polyA signal sequences inhibits
splicing and favors intronic sFlt1 processing. However,
despite mutation of all known intronic polyA signal
sequences, there is suﬃcient sFlt1 processing which
suggests that there may be cryptic polyA signal sequences
that still direct RNA processing to intronic sFlt1. These
cryptic polyA signal sequences must be near the three
known pA signal sequences as deletion of both proximal
and distal pA signal sequences and sequence adjacent is
suﬃcient to direct RNA processing to splicing (Figure 7B
and C). We have no reason to believe that these cryptic
splice sites operate normally or are biologically relevant as
we did not ﬁnd any other endogenous pA site usage within
intron 13 by 30 RACE and by RPA nor did we did ﬁnd
evidence of other pA site usage in EST databases (11).
Our data thus far demonstrates that cis-elements within
intron 13 inhibit splicing of exon 13 to exon 14 and thus
the synthesis of full-length Flt1 as well as other sFlt1 tran-
scripts. To determine if downstream exons inﬂuence
intronic polyadenylation and processing to sFlt1, we
created minigene constructs with combinations of exons
13, 14 and 15 along with intervening sequence and
measured processed transcripts by qRT–PCR in JEG-3
and COS-7 cells. Following transfection, the spliced tran-
script was ampliﬁed by primers in the ﬂanking exons 2 and
3 of insulin while the chimeric transcript that reads into
intron 13 without splicing downstream was ampliﬁed by a
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Figure 5. A distal intron 13 region reduces splicing of heterologous
exons. (A) Schematic representation of pL53In with and without the
inserted sequence from the distal end of FLT1 intron 13. The schematic
representation shows two possible processed products—one from
splicing of exon 2 to exon 3 and one unspliced product that uses
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Figure 6. Identiﬁcation of sFlt1 mRNA proximal intronic cleavage site
with the reporter vector pCbS. (A) Schematic representation of the
pCbS vector with sFlt1 proximal fragment inserted downstream of
the CMV promoter to create pCbs/sFlt1 prox. (B and C)p C bS/sFlt1
prox or pCbs/sFlt1proxmut was transfected into HTR-8/SVNeo cells
and then isolated mRNA was probed by RPA with a cRNA derived
from the corresponding plasmid. A strong band in (B) lane 1 at  170
represents cleavage directed by the putative proximal intronic sFlt1
poly(A) signal sequence. Mutation of the proximal signal leads to
loss of the primary cleavage at  170 in (C) lane 1. A weak band at
 190 seen in lane 1 (C), probably represents cleavage directed by a
cryptic poly(A) signal sequence. The signal sequence is boxed in
sequence above (B and C). Digested RNA samples were run alongside
yeast RNA (negative control) and (undigested) probe.
5136 Nucleic Acids Research, 2010,Vol.38, No. 15forward primer within insulin exon 2 and a reverse primer
within Flt1 intron 13. We demonstrate that inclusion of
exon 13 with adjacent intron 13 inhibits splicing down-
stream, seen as a poorly ampliﬁed PCR product (Figure
8A, lanes 2 and 4, upper panel). Similar data is obtained
even if exon 15 is substituted for exon 14 where upstream
intron 13 sequences inhibit splicing (Figure 8C, lanes 3
and 4, upper panel). Although minigene constructs that
include exon 13 and intron 13 inhibit splicing downstream,
these constructs can fully support the alternate processing
of sFlt1 as conﬁrmed by the ampliﬁcation of an intronic
sFlt1 product wherever exon 13 and adjacent intron is
present (Figure 8A and C, lower panel). Exons 14 and
15 are intrinsically capable of supporting splicing in
these minigene constructs as a single robust spliced
product that includes exon 14 or exon 15 is seen when
these were tested them without intron 13 (Figure 8A and
C). Furthermore, we demonstrate that the inclusion of
exon 15 has a modest stimulatory eﬀect on the abundance
of processed sFlt1 (Figure 8B and D). Qualitatively similar
data was obtained in COS-7 cells (data not shown). We
conclude that the strength of the intronic poly(A) signal
sequence and adjacent cis elements and that of trans-
acting factors that direct mRNA cleavage and
polyadenylation are the primary determinants of the
relative ratio of intronic sFlt1 to Flt1.
DISCUSSION
Angiogenesis and vasculogenesis require the carefully
coordinated, spatially directed, elaboration of pro- and
anti-angiogenic factors in a tissue and organ-speciﬁc
fashion. The angiogenic growth factors signal via their
cognate receptors expressed on the surface of target
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Figure 7. Regions containing intronic poly(A) signal sequences regulate relative abundance of Flt1. (A and D) Schematic representation of human
FLT1 gene in the region of exons 13 and 14. The relative position of the deletions (A) or mutations (D) are shown. (B and E) RPA demonstrating
relative abundance of processed sFlt1 and processed Flt1 in cells transfected with Flt1 minigene constructs. The full-length construct leads primarily
to processed sFlt1, and deletions (B) or mutations (E) of the proximal poly(A) alone or together with distal poly(A) increases the abundance of
processed Flt1. (C) Pooled quantitated data with Flt1 expressed as a ratio of sFlt1 demonstrates that deletion of both the proximal and distal pA
region robustly stimulates splicing. n=3, mean±SEM, P<0.005, ANOVA by ranks, *P<0.05 compared to full length. (F) Pooled quantitated
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Nucleic Acids Research, 2010,Vol.38, No. 15 5137cells. One of these growth factor receptors, Flt1, is
co-expressed with a soluble receptor, sFlt1, which binds
VEGF and PlGF with equal aﬃnity and can eﬀectively
regulate the free or active ligand in the extracellular
milieu. When expressed in excess of the full-length cell
surface receptor, sFlt1 can neutralize the eﬀect of VEGF
both locally and in distant sites such as the glomerulus.
We have previously demonstrated that sFlt1 is produced
in greater excess compared to Flt1 in cytotrophoblasts and
in the placenta under basal conditions (11,14). We and
others have identiﬁed multiple sFlt1 transcripts, including
three transcripts that utilize intronic polyadenylation
signal sequences in intron 13 to create a composite
30-terminal exon and others that splice normally from
exon 13 to exon 14 and then use a polyA signal within
intron 14 or within alternate terminal exons 15a and 15b
(11,13). We now demonstrate that activation of PKC in
vascular endothelial cells and induction by hypoxia in
trophoblasts leads to a robust and disproportionate
increase in the intron 13 form of sFlt1 compared to
Flt1. This prompted us to examine the regulation of this
intronic form of sFlt1.
We proceeded to deﬁne regulatory elements within the
Flt1 gene that regulates the abundance of intronic sFlt1
compared to all other Flt1/sFlt1 transcripts. Cis-acting
factors that may regulate the processing of intronic sFlt1
include the number and strength of poly(A) signal se-
quences for sFlt1 and/or the relative distance between
the sFlt1 cleavage sites and the downstream exon 14. On
the other hand, regulation of spliced Flt1 expression may
be dictated by the strength of the 50 and 30 splice sites that
permit splicing of exon 13 to exon 14 or exon 14 to exon
15 and/or the presence of an exonic splicing silencer (ESS)
within exon 13 or a downstream exon. Cis-elements that
may simultaneously and reciprocally regulate the abun-
dance of intronic sFlt1 and spliced ‘Flt1’ include strong
poly(A) signal sequences within intron 13. Using a com-
bination of methods, we conclude that the primary deter-
minants of the relative ratio of intronic sFlt1 to spliced
‘Flt1’ are the intronic poly(A) signal sequences and
adjacent cis elements, although cis-elements in or
adjacent to downstream exons may also contribute. A
review of intron 13 sequence across species using the
ECR browser and rVista (http://rvista.dcode.org) and
megaBlast (http://www.ncbi.nlm.nih.gov/genome/seq/
BlastGen/BlastGen.cgi?taxid=9606) demonstrates that
there is a high degree of conservation of cis-elements
including proximal and distal polyA signal sequences
from monodelphis to Homo sapiens (Table 2). Although
intronic sFlt1 is also expressed in avians, the only
sequenced sFlt1 transcript, in chickens, appears to have
just the proximal signal sequence. The later appearance of
the distal intronic polyA signal sequences with its subse-
quent ﬁxation in the genome implies that the distal signals
provided a strong survival advantage for the species.
The ﬁndings that we report here and our previous
studies demonstrate that sFlt1 is expressed at far greater
abundance in CTB compared to Flt1 (12). In the current
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Figure 8. Eﬀect of downstream exons on processing to sFlt1. A series of minigene constructs containing exons 13, 14 and 15 with intervening
sequence in various combinations were transfected into JEG-3 cells and Flt1 splicing, and sFlt1 processing were analyzed by qRT–PCR. (A and C)
Products of PCR reactions analyzed by gel electrophoresis. Schematic representation above each lane demonstrates sequences within minigene
construct and schematic to the right indicates the position of primers used. When exon 13 and intron 13 sequences are present, splicing downstream
is inhibited with multiple products of low abundance seen (upper portion of A and C). Transfected minigenes are however eﬃciently processed to
sFlt1 (lower portion of A and C) when exon 13 and intron 13 are present. (B and D) Eﬀect of exon 15 on sFlt1 processing compared to exon 14.
Exon 15 signiﬁcantly increases processing to sFlt1.
5138 Nucleic Acids Research, 2010,Vol.38, No. 15study, we use a minigene construct where exon 13 and 14
and the intervening sequence were tested to identify cis-
elements within intron 13 that reciprocally regulate the
abundance of intronic sFlt1 and spliced Flt1. In the
native gene, there are likely to be additional cis-regulatory
elements and trans-acting factors that determine intronic
polyadenylation versus splicing of exon 13 to exon 14 and
beyond. While Flt1 is expressed in relatively lower abun-
dance in CTB, at least one other transcript that requires
splicing of exon 13 to exon 14, sFlt1-e15a, is expressed at
high levels. A simple competition between intronic
poly(A) signal sequences and splice donor or acceptor
sites in exon 13 or 14 does not fully explain the relatively
high abundance of both sFlt1-i13 and sFlt1-e15a. There
may be, for example, speciﬁc repression of splice sites
downstream of exon 15a that allows both intronic and
spliced forms of sFlt1 to be expressed at high levels
without correspondingly high levels of expression of
Flt1. Minigene constructs that include more downstream
exons and chromatin immunoprecipitation analysis of
splice site occupancy may provide additional information
on physiological regulation of Flt1 gene expression.
Large-scale computational analysis of the human
genome has revealed that alternate polyadenylation
events occur in over 50% of known human genes (21).
The pattern of upstream polyadenylation that we
describe here arises from polyadenylation signal sequences
within intron 13 that convert an internal exon (exon 13) to
a composite 30-terminal exon (18,22). This composite
terminal exon leading to the classic intronic sFlt1 tran-
script and the resulting protein isoform has been
conserved from chicken to human. Generally, the
features associated with composite terminal exons
include large introns, strong polyA signal sequences and
weak 50 skipped splice sites with the median distance
between the composite exon polyA site and the skipped
splice site between 238 and 355nt (23). Although the ﬁrst
polyA signal sequence is 101nt from the 50 skipped splice
site, unusually, the more robust polyA signal sequence is
found >4100nt away from the 50 skipped splice site.
As expected, one of the distal polyA signal sequences is
the strong classic sequence, (AATAAA) although the 50
splice site is also strong (GAG|GTGAGC) with diver-
gent nt only at  3 and +6 from the consensus
MAG|GTRAGT. A recent analysis of the human tran-
scriptome demonstrated that 80% of tandem polyA
signal sequences show tissue-speciﬁc regulation and it is
possible that there are tissue-speciﬁc diﬀerences in utiliza-
tion of the proximal and distal intronic sFlt1 pA signal
sequences; this may merit future study (24).
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